These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 38599828)

  • 21. Relationship between cardiac tissue glycation and skin autofluorescence in patients with coronary artery disease.
    Hofmann B; Jacobs K; Navarrete Santos A; Wienke A; Silber RE; Simm A
    Diabetes Metab; 2015 Nov; 41(5):410-5. PubMed ID: 25553578
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of Skin Autofluorescence Levels With Kidney Function Decline in Patients With Peripheral Artery Disease.
    Schutte E; de Vos LC; Lutgers HL; Lambers Heerspink HJ; Wolffenbuttel BH; Vart P; Zeebregts CJ; Gansevoort RT; Lefrandt JD
    Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1709-14. PubMed ID: 27365407
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Advanced glycation end-products, measured as skin autofluorescence, associate with vascular stiffness in diabetic, pre-diabetic and normoglycemic individuals: a cross-sectional study.
    Birukov A; Cuadrat R; Polemiti E; Eichelmann F; Schulze MB
    Cardiovasc Diabetol; 2021 Jun; 20(1):110. PubMed ID: 34176469
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Skin autofluorescence as a measure of advanced glycation end products deposition is elevated in peripheral artery disease.
    de Vos LC; Noordzij MJ; Mulder DJ; Smit AJ; Lutgers HL; Dullaart RP; Kamphuisen PW; Zeebregts CJ; Lefrandt JD
    Arterioscler Thromb Vasc Biol; 2013 Jan; 33(1):131-8. PubMed ID: 23139292
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of skin autofluorescence with plaque vulnerability evaluated by optical coherence tomography in patients with cardiovascular disease.
    Fujino Y; Attizzani GF; Tahara S; Wang W; Takagi K; Naganuma T; Yabushita H; Tanaka K; Sato T; Watanabe Y; Mitomo S; Kurita N; Ishiguro H; Nakamura S; Hozawa K; Bezerra HG; Yamagishi SI; Nakamura S
    Atherosclerosis; 2018 Jul; 274():47-53. PubMed ID: 29751284
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Skin autofluorescence of advanced glycation end-products relates to new cardiovascular events in type 2 diabetes: A longitudinal observational study.
    Alkhami F; Borderie G; Foussard N; Larroumet A; Blanco L; Barbet-Massin MA; Ferriere A; Ducos C; Mohammedi K; Fawaz S; Couffinhal T; Rigalleau V
    Diabetes Metab; 2024 Mar; 50(2):101524. PubMed ID: 38346471
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Skin autofluorescence of Advanced Glycation End-products and mortality in older adults: The roles of chronic kidney disease and diabetes.
    Majchrzak C; Cougnard-Gregoire A; Le-Goff M; Féart C; Delcourt C; Reydit M; Helmer C; Rigalleau V
    Nutr Metab Cardiovasc Dis; 2022 Nov; 32(11):2526-2533. PubMed ID: 36064683
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of Advanced Glycation End Products With Lower-Extremity Atherosclerotic Disease in Type 2 Diabetes Mellitus.
    Ying L; Shen Y; Zhang Y; Wang Y; Liu Y; Yin J; Wang Y; Yin J; Zhu W; Bao Y; Zhou J
    Front Cardiovasc Med; 2021; 8():696156. PubMed ID: 34568445
    [No Abstract]   [Full Text] [Related]  

  • 29. Advanced glycation end-products (AGEs) accumulation in skin: relations with chronic kidney disease-mineral and bone disorder.
    França RA; Esteves ABA; Borges CM; Quadros KRDS; Falcão LCN; Caramori JCT; Oliveira RB
    J Bras Nefrol; 2017; 39(3):253-260. PubMed ID: 28902232
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Skin Autofluorescence Is Associated with Diabetic Peripheral Neuropathy in Chinese Patients with Type 2 Diabetes: A Cross-Sectional Study.
    Wan L; Qin G; Yan W; Sun T
    Genet Test Mol Biomarkers; 2019 Jun; 23(6):387-392. PubMed ID: 31161820
    [No Abstract]   [Full Text] [Related]  

  • 31. Higher habitual intake of dietary dicarbonyls is associated with higher corresponding plasma dicarbonyl concentrations and skin autofluorescence: the Maastricht Study.
    Maasen K; Eussen SJPM; Scheijen JLJM; van der Kallen CJH; Dagnelie PC; Opperhuizen A; Stehouwer CDA; van Greevenbroek MMJ; Schalkwijk CG
    Am J Clin Nutr; 2022 Jan; 115(1):34-44. PubMed ID: 34625788
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mediterranean diet, physical activity and subcutaneous advanced glycation end-products' accumulation: a cross-sectional analysis in the ILERVAS project.
    Sánchez E; Betriu À; Salas-Salvadó J; Pamplona R; Barbé F; Purroy F; Farràs C; Fernández E; López-Cano C; Mizab C; Lecube A;
    Eur J Nutr; 2020 Apr; 59(3):1233-1242. PubMed ID: 31065845
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Skin Autofluorescence Measurement in Subclinical Atheromatous Disease: Results from the ILERVAS Project.
    Sánchez E; Betriu À; Yeramian A; Fernández E; Purroy F; Sánchez-de-la-Torre M; Pamplona R; Miquel E; Kerkeni M; Hernández C; Simó R; Lecube A; ; ; Hernández M; Rius F; Polanco D; Barbé F; Torres G; Suárez G; Portero-Otin M; Jové M; Colàs-Campàs L; Benabdelhak I; Farràs C; Ortega M; Manuel Valdivielso J; Bermúdez-López M; Martínez-Alonso M
    J Atheroscler Thromb; 2019 Oct; 26(10):879-889. PubMed ID: 30842389
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationship between skin autofluorescence levels and clinical events in patients with heart failure undergoing cardiac rehabilitation.
    Kunimoto M; Yokoyama M; Shimada K; Matsubara T; Aikawa T; Ouchi S; Fukao K; Miyazaki T; Fujiwara K; Abulimiti A; Honzawa A; Shimada A; Yamamoto T; Amano A; Saitoh M; Morisawa T; Takahashi T; Daida H; Minamino T
    Cardiovasc Diabetol; 2021 Oct; 20(1):208. PubMed ID: 34656131
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Skin autofluorescence as a measure of advanced glycation end products deposition predicts 5-year amputation in patients with peripheral artery disease.
    de Vos LC; Boersema J; Mulder DJ; Smit AJ; Zeebregts CJ; Lefrandt JD
    Arterioscler Thromb Vasc Biol; 2015 Jun; 35(6):1532-7. PubMed ID: 25882066
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A physically active lifestyle is related to a lower level of skin autofluorescence in a large population with chronic-disease (LifeLines cohort).
    van de Zande SC; de Vries JK; van den Akker-Scheek I; Zwerver J; Smit AJ
    J Sport Health Sci; 2022 Mar; 11(2):260-265. PubMed ID: 32987221
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased skin autofluorescence of children and adolescents with type 1 diabetes despite a well-controlled HbA1c: results from a cohort study.
    van der Heyden JC; Birnie E; Mul D; Bovenberg S; Veeze HJ; Aanstoot HJ
    BMC Endocr Disord; 2016 Sep; 16(1):49. PubMed ID: 27613110
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Skin autofluorescence, a non-invasive biomarker of advanced glycation end products, and its relation to radiographic and MRI based osteoarthritis.
    Waqas K; Szilagyi IA; Schiphof D; Boer CG; Bierma-Zeinstra S; van Meurs JBJ; Zillikens MC
    Osteoarthritis Cartilage; 2022 Dec; 30(12):1631-1639. PubMed ID: 36087928
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association between advanced glycation end-products and fall risk in older adults: The Yakumo Study.
    Iida H; Takegami Y; Osawa Y; Funahashi H; Ozawa Y; Ido H; Asamoto T; Otaka K; Tanaka S; Nakashima H; Ishizuka S; Seki T; Hasegawa Y; Imagama S
    Geriatr Gerontol Int; 2024 Jun; 24(6):517-522. PubMed ID: 38644665
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Skin autofluorescence, arterial stiffness and Framingham risk score as predictors of clinical outcome in chronic kidney disease patients: a cohort study.
    Mukai H; Svedberg O; Lindholm B; Dai L; Heimbürger O; Barany P; Anderstam B; Stenvinkel P; Qureshi AR
    Nephrol Dial Transplant; 2019 Mar; 34(3):442-448. PubMed ID: 29378035
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.